AMANDA BERRY: Open Payments
NPI 1386336071 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 19 payments from 10 companies in 2025. Trend: 2023 $168 · 2024 $674 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $166 |
| Lilly USA, LLC | 2 | $142 |
| REVANCE THERAPEUTICS, INC. | 1 | $133 |
| Amgen Inc. | 6 | $107 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $50 |
| Galderma Laboratories, L.P. | 2 | $33 |
| PFIZER INC. | 1 | $20 |
| Chiesi USA, Inc. | 1 | $20 |
| Averitas Pharma Inc. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: MINIMED 780G, DAXXIFY, MOUNJARO, TEPEZZA, ISTURISA, SOMAVERT, MYCAPSSA, JARDIANCE.
Industry payments across MI — which companies pay providers there.
